p53 Mutation does not determine prognosis in non-hodgkin's lymphoma

M. Osada, C. Ishioka, Y. Murakawa, R. Ichinohasama, R. Kanamaru, S. Ikawa

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


We studied the clinical significance of the extent of p53 protein expression by immunohistochemical analysis and p53 mutations by functional analysis of p53 in 42 patients with high and intermediate grade of Non- Hodgkin's Lymphoma (NHL). Neither p53 expression nor mutation correlated with short survival or resistance to chemoradiotherapy, implying that p53 mutation is not a prognostic factor in NHL.

Original languageEnglish
Pages (from-to)471-475
Number of pages5
JournalJapanese Journal of Cancer and Chemotherapy
Issue number4
Publication statusPublished - 1997


  • Non-Hodgkin's lymphoma
  • p53


Dive into the research topics of 'p53 Mutation does not determine prognosis in non-hodgkin's lymphoma'. Together they form a unique fingerprint.

Cite this